Answers are grounded in this paper and cite their sources.
Reveals that adding Intralipid to standard resuscitation decreases return of spontaneous circulation after hypoxic cardiac arrest in rabbits, indicating potential harm during hypoxic arrest.
In Brief BACKGROUND: Infusion of lipid emulsion has been shown to reverse lipophilic drug-induced cardiovascular collapse in laboratory models and humans. The effect of high dose lipid in nondrug-induced cardiac arrest is, however, uncertain. In a rabbit model of asphyxial pulseless electrical activity (PEA) we compared lipid augmented with standard advanced cardiac life support (ACLS) resuscitation. METHOD: Adult New Zealand White rabbits underwent hypoxic PEA via tracheal clamping. After 2 min of cardiac arrest, basic life support cardiopulmonary resuscitation was commenced and 3 mL/kg 20% Intralipid or 3 mL/kg 0.9% saline solution infused. Adrenaline (100 μg/kg) was administered at 4 and 5 min. Return of spontaneous circulation (ROSC), hemodynamic metrics, and survival to 50 min were recorded. RESULTS: Seven of 11 saline-treated rabbits developed ROSC versus 1 of 12 Intralipid-treated animals; P = 0.009. No significant difference in survival to 50 min was observed (3/11 saline vs 0/12 Intralipid; P = 0.211). CONCLUSION: In this model of hypoxia-induced PEA, standard ACLS resulted in greater coronary perfusion pressure and increased ROSC compared with ACLS plus lipid infusion. Lipid emulsion may be contraindicated in cardiac arrest complicated by significant hypoxia. IMPLICATIONS: In this intact rabbit model of hypoxic pulseless electrical activity, infusion of lipid emulsion in addition to standard resuscitative measures resulted in lesser developed coronary perfusion pressure and diminished return of spontaneous circulation. Clinicians considering lipid in the clinical scenario of cardiovascular collapse attributable to a cardiotoxic drug of high lipophilicity should consider optimization of oxygenation, ventilation, and coronary perfusion prerequisite. Consideration for lipid when lipophilic drug cardiac toxicity is suspected, but unproven, must be approached with some caution.
No takes yet. Share an insight, caveat, or question.
Harvey et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: